Stockscreener 앱 받기
0.8984
12.78%
-0.1316
전일 마감가:
$1.03
열려 있는:
$0.9094
하루 거래량:
89,024
Relative Volume:
0.36
시가총액:
$44.76M
수익:
$2.82M
순이익/손실:
$-13.47M
주가수익비율:
-1.3212
EPS:
-0.68
순현금흐름:
$-13.61M
1주 성능:
+24.17%
1개월 성능:
+35.65%
6개월 성능:
-19.79%
1년 성능:
+8.24%
1일 변동 폭
$0.8901
$0.918
1주일 범위
$0.7235
$1.04
52주 변동 폭
$0.3954
$1.39
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
명칭
Neuroone Medical Technologies Corp
전화
(952) 426-1383
주소
7599 ANAGRAM DR, EDEN PRAIRIE
NMTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.56 | 689.87M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.30 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.70 | 117.84M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1599 | 317.05M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.3733 | 0 | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-05 | 개시 | Ladenburg Thalmann | Buy |
| 2022-03-29 | 다운그레이드 | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp 주식(NMTC)의 최신 뉴스
What drives NeuroOne Medical Technologies Corporation stock priceSuperior capital gains - Autocar Professional
NeuroOne receives USPTO patent allowance for neural probe technology By Investing.com - Investing.com South Africa
NeuroOne Medical Technologies Secures Notice of Allowance for Key Neural Probe Patent - Quiver Quantitative
NeuroOne receives patent allowance for neural probe technology - Investing.com
NeuroOne Strengthens Neural Tech Leadership with Strategic USPTO Patent for Advanced Electrode Technology - Stock Titan
What analysts say about NeuroOne Medical Technologies Corporation stockOverwhelming profit margins - Autocar Professional
Is NeuroOne Medical Technologies Corporation a good long term investmentBreakout profit opportunities - jammulinksnews.com
NeuroOne Medical Technologies Corporation Stock Analysis and ForecastAccelerated investment success - jammulinksnews.com
81,000 Shares in NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Bought by Cambridge Investment Research Advisors Inc. - Defense World
Why NeuroOne Medical Technologies Corporation stock attracts strong analyst attentionBreakout Momentum Stocks - Newser
What makes NeuroOne Medical Technologies Corporation stock price move sharplySmart Money Trade Setups - Newser
How NeuroOne Medical Technologies Corporation stock performs during market volatilityHigh Return Intraday Picks - Newser
Revolutionary OneRF Treatment Transforms Patient's Life: From 10 Daily Seizures to Complete Freedom for 1 Year - Stock Titan
Certain Warrants of NeuroOne Medical Technologies Corporation are subject to a Lock-Up Agreement Ending on 19-JUN-2025. - MarketScreener
Certain Common Stock of NeuroOne Medical Technologies Corporation are subject to a Lock-Up Agreement Ending on 19-JUN-2025. - MarketScreener
Jane Street Group LLC Takes $33,000 Position in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) - Defense World
NeuroOne Medical (NMTC) Enhances Leadership with New General Cou - GuruFocus
NeuroOne Cuts Legal Costs with Strategic General Counsel Hire: Former Partner Joins Executive Team - Stock Titan
NeuroOne CEO to Meet Investors at MedInvest Conference: Spotlight on Neural Surgery Innovation - Stock Titan
NeuroOne Medical Technologies (NASDAQ:NMTC) Trading 1.1% Higher – Should You Buy? - Defense World
NeuroOne Completes FDA Submission for OneRF Trigeminal Nerve Ablation System - Medical Product Outsourcing
NeuroOne Medical Technologies Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
NMTC Achieves Growth in Q2 with Advancements in OneRF Technology - GuruFocus
Earnings call transcript: NeuroOne Medical beats EPS expectations in Q1 2025 - Investing.com Canada
NeuroOne Medical Technologies Corp (NMTC) Q2 2025 Earnings Call Highlights: Revenue Surge and ... - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Q2 2025 Earnings Call - GuruFocus
NeuroOne Medical Technologies Corp Reports Q2 FY2025 Earnings: E - GuruFocus
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6% - Stock Titan
NeuroOne Medical (NMTC) Welcomes New Chief Medical Advisor | NMT - GuruFocus
NeuroOne Medical Technologies (NMTC) Appoints New Chief Medical Advisor - GuruFocus
NeuroOne appoints Dr. Patil as Chief Medical Advisor - Investing.com
NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor - Stock Titan
NeuroOne Medical Opens Exclusive Investor Access: CFO Hosts One-on-One Meetings at Plaza Hotel - Stock Titan
NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference - The Kingston Whig Standard
NeuroOne Medical Tech (NMTC) Coverage Initiated by Ladenburg Tha - GuruFocus
This Okta Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Geode Capital Management LLC Grows Stake in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) - Defense World
NeuroOne Earnings: Medical Tech Leader to Reveal Q2 2025 Growth Strategy and Financial Results - Stock Titan
NeuroOne Medical Technologies Corp [NMTC] Records 50-Day SMA of $0.8911 - knoxdaily.com
NeuroOne Medical Technologies Corp’s results are impressive - uspostnews.com
The Future of NeuroOne Medical Technologies Corp: Analyzing NMTC - investchronicle.com
NeuroOne Medical (NMTC) Files Early FDA Submission for Trigemina - GuruFocus
NeuroOne Medical (NMTC) Files Early FDA Submission for Trigeminal Nerve Ablation | NMTC Stock News - GuruFocus
NeuroOne files early FDA 510(k) for nerve ablation system - Investing.com
NeuroOne's Revolutionary Facial Pain Treatment Advances: FDA Review Next for 95% Effective Device - Stock Titan
EXCLUSIVE: NeuroOne Submits FDA Marketing Application For OneRF Trigeminal Nerve Ablation System For Facial Pain - Benzinga
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Regulatory Success ... - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call - GuruFocus
Neuroone Medical Technologies Corp (NMTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
자본화:
|
볼륨(24시간):